Buspirone Hydrochloride Tablets Recalled for Foreign Tablet Contamination
Oxford Pharmaceuticals is recalling 6,864 bottles of Buspirone Hydrochloride Tablets, 15 mg, distributed nationwide due to the presence of foreign tablets or capsules in the product.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving foreign tablet contamination in a prescription medication, creating a risk of patient harm through unintended drug exposure. Although no reported illnesses or injuries are stated in the source text, the hazard is significant and involves risk of administering an unknown substance to patients.
Plain-English summary
Oxford Pharmaceuticals, LLC is recalling Buspirone Hydrochloride Tablets, USP, 15 mg, 100-count bottles (Lot #C21021A, expiration 03/2023, NDC 69584-093-10) distributed nationwide. Approximately 6,864 bottles are affected by this recall.
The recall is due to the presence of foreign tablets or capsules in the product. This contamination could result in patients receiving unintended medication.
Patients taking this product should discontinue use and contact their pharmacy or healthcare provider. Consumers who have this medication should return it to the place of purchase or contact Oxford Pharmaceuticals for further instructions.
The recalled product
- Product
- BUSPIRONE HYDROCHLORIDE (BUSPIRONE HYDROCHLORIDE)
- Brand
- BUSPIRONE HYDROCHLORIDE
- Manufacturer
- Oxford Pharmaceuticals, LLC
- Hazard
- foreign-tablet-contamination
- product-contamination
- wrong-medication-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: C21021A
- Exp. 03/2023
UPCs (1)
- 0369584093502
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · BUSPIRONE HYDROCHLORIDE
- LowBuspirone Hydrochloride Tablets 5 mg Recalled for Subpotency
FDA (Drugs) · 2026-05-13
- ModerateLisinopril Tablets Recalled for Stray Amlodipine Tablet Contamination
FDA (Drugs) · 2023-11-29
- HighBuspirone Hydrochloride Tablets Recalled Due To Amlodipine Contamination Risk
FDA (Drugs) · 2023-11-29
- ModerateDrug Recall: Buspirone Tablets Over Manufacturing Process Deviations
FDA (Drugs) · 2023-05-03
- ModerateBuspirone Hydrochloride tablets recalled for manufacturing practice deviations
FDA (Drugs) · 2023-03-08
Same category
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateClinere Ear Wax Remover Recalled for Subpotent Carbamide Peroxide
FDA (Drugs) · 2026-07-22